Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone

Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone

Purpose: Tumor microRNAs (miRNAs) are released to biofluids directly or indirectly. Although urinary miRNAs are promising non-invasive biomarkers for the diagnosis of prostate cancer (PCa), their clinical application is challenging for technical reasons. We examined the efficacy of urinary hsv2-miR-...

Full description

Bibliographic Details
Main Authors: Ho Won Kang, Young Joon Byun, Sung Min Moon, Kyeong Kim, Xuan-Mei Piao, Chuang-Ming Zheng, Sung-Kwon Moon, Yung Hyun Choi, Won Tae Kim, Yong-June Kim, Sang-Cheol Lee, Seok Joong Yun, Wun-Jae Kim
Format: Article
Language:English
Published: Korean Urological Association 2022-03-01
Series:Investigative and Clinical Urology
Subjects:
biomarker
diagnosis
microarray analysis
micrornas
prostatic neoplasms
Online Access:https://www.icurology.org/pdf/10.4111/icu.20210493

Internet

https://www.icurology.org/pdf/10.4111/icu.20210493

Similar Items